Literature DB >> 9606005

Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.

C F Bennett1, D Mirejovsky, R M Crooke, Y J Tsai, J Felgner, C N Sridhar, C J Wheeler, P L Felgner.   

Abstract

A series of 2,3-dialkyloxypropyl quaternary ammonium lipids containing hydroxyalkyl chains on the quaternary amine were synthesized, formulated with dioleoylphosphatidylethanolamine (DOPE) and assayed for their ability to enhance the activity of an intercellular adhesion molecule 1 (ICAM-1) antisense oligonucleotide, ISIS 1570. Cationic liposomes prepared with hydroxyethyl, hydroxypropyl and hydroxybutyl substituted cationic lipid all enhanced the activity of the ICAM-1 antisense oligonucleotide. Cationic lipids containing hydroxypentyl quaternary amines only marginally enhanced the activity of ISIS 1570. Hydroxyethyl cationic lipids synthesized with dimyristyl (Cl4:0) and dioleyl (C18:1) alkyl chains were equally effective. Activity of cationic lipids containing saturated alkyl groups decreased as the chain length increased, i.e. the dimyristyl (C14:0) was more effective than dipalmityl (C16:0) lipid, which was more effective than distearyl (C18:0). The phase transition temperature of cationic lipids containing saturated aliphatic chains was 56 degrees C for the distearyl lipid, 42 degrees C for the dipalmityl lipid and 24 degrees C for the dimyristyl lipid. Cationic lipids with dioleyl alkyl chains required DOPE for activity, with optimal activity occurring at 50 mole%. In contrast, a dimyristyl containing cationic lipid did not require DOPE to enhance the activity of ISIS 1570. Formulation with different phosphatidylethanolamine derivatives, revealed that optimal activity was obtained with DOPE. These studies demonstrate that several cationic lipid species enhance the activity of phosphorothioate antisense oligonucleotides and provide further information on the mechanism by which cationic lipids enhance the activity of phosphorothioate oligodeoxynucleotides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606005     DOI: 10.3109/10611869808995870

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  6 in total

1.  Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes.

Authors:  Marilyn E Ferrari; Denis Rusalov; Joel Enas; Carl J Wheeler
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

2.  Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.

Authors:  R Chakraborty; D Dasgupta; S Adhya; M K Basu
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

3.  Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles.

Authors:  M Berton; P Turelli; D Trono; C A Stein; E Allémann; R Gurny
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

4.  The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.

Authors:  William Boland; Gwyn Bebb
Journal:  Biologics       Date:  2010-11-09

5.  Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation, and transfection efficiency.

Authors:  Inge S Zuhorn; Volker Oberle; Willy H Visser; Jan B F N Engberts; Udo Bakowsky; Evgeny Polushkin; Dick Hoekstra
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

Review 6.  Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties.

Authors:  Giuseppe De Rosa; Maria Immacolata La Rotonda
Journal:  Molecules       Date:  2009-07-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.